Please login to the form below

Not currently logged in

Bayer to spin out material science division

Bayer symbol

German firm will focus solely on life sciences

Novo Nordisk's Xultophy diabetes combo approved in Europe

Novo Nordisk headquartersOnce-daily injection combines the firm's Tresiba and Victoza

FDA approves Lilly’s GLP-1 diabetes drug Trulicity

Eli Lilly HQ thumbThe once-weekly treatment is set to compete with Bydureon, Tanzeum and Victoza

NICE fast-tracks GSK's skin cancer drug Tafinlar

GSK - logo on buildingBut only on condition the company cuts its price

Boehringer signs €465m lung cancer vaccine deal

Boehringer Ingelheim headquartersLicenses CureVac's cancer immunotherapy CV9202

Sanofi licenses cardiomyopathy programme in $200m deal

Sanofi receptionHas rights to three of MyoKardia’s programmes

Pfizer acquires option to license potential Parkinson’s treatment

Pfizer headquartersMedgenesis cuts exclusive deal for its GDNF treatment

FDA approves AZ's opioid-induced constipation drug Movantik

FDA headquarters White OakTrials showed positive reactions to the treatment

Gilead's simtuzumab fails pancreatic cancer trial

Gilead Sciences buildingShowed little difference in progression-free survival compared to placebo results

GSK consumer healthcarePharma is turning its attention to consumer healthcare

Pharma is no stranger to over-the-counter remedies but, as a number of recent deals show, consumer healthcare’s star is rising

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Concentric Advertising London

We're an independent agency that prides itself on independent thinking. Under one roof we've gathered a rich pool of talent,...

Latest intelligence

The heart of the matter: Part Two
How is social media impacting publication planning?...
digital numbers
Seven steps to innovating your digital strategy
Dealing with digitally native HCPs...
Online Physician Communities
Online learning increasingly popular for doctors
Sponsorship can help companies raise their profile specific therapy areas...